Center-Authored Papers

Filters: Author is Witherspoon, Robert P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
Furlong T, Martin PJ, Flowers MED, Carnevale-Schianca F, Yatscoff R, Chauncey TR, Appelbaum FR, Deeg HJ, Doney K, Witherspoon RP et al..  2009.  Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.. Bone marrow transplantation. 44(11):739-48. Abstract
McCune JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
2011
Inamoto Y, Flowers MED, Appelbaum FR, Carpenter PA, Deeg HJ, Furlong T, Kiem H-P, Mielcarek M, Nash RA, Storb R et al..  2011.  A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):1088-92. Abstract
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney K, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE et al..  2011.  Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):341-50. Abstract
Acute Disease
McCune JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
Administration, Oral
Furlong T, Martin PJ, Flowers MED, Carnevale-Schianca F, Yatscoff R, Chauncey TR, Appelbaum FR, Deeg HJ, Doney K, Witherspoon RP et al..  2009.  Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.. Bone marrow transplantation. 44(11):739-48. Abstract
Adolescent
McCune JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney K, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE et al..  2011.  Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):341-50. Abstract
Inamoto Y, Flowers MED, Appelbaum FR, Carpenter PA, Deeg HJ, Furlong T, Kiem H-P, Mielcarek M, Nash RA, Storb R et al..  2011.  A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):1088-92. Abstract
Furlong T, Martin PJ, Flowers MED, Carnevale-Schianca F, Yatscoff R, Chauncey TR, Appelbaum FR, Deeg HJ, Doney K, Witherspoon RP et al..  2009.  Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.. Bone marrow transplantation. 44(11):739-48. Abstract
Adult
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney K, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE et al..  2011.  Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):341-50. Abstract
McCune JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
Inamoto Y, Flowers MED, Appelbaum FR, Carpenter PA, Deeg HJ, Furlong T, Kiem H-P, Mielcarek M, Nash RA, Storb R et al..  2011.  A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):1088-92. Abstract
Furlong T, Martin PJ, Flowers MED, Carnevale-Schianca F, Yatscoff R, Chauncey TR, Appelbaum FR, Deeg HJ, Doney K, Witherspoon RP et al..  2009.  Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.. Bone marrow transplantation. 44(11):739-48. Abstract
Age Factors
McCune JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
Aged
Inamoto Y, Flowers MED, Appelbaum FR, Carpenter PA, Deeg HJ, Furlong T, Kiem H-P, Mielcarek M, Nash RA, Storb R et al..  2011.  A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):1088-92. Abstract
Antineoplastic Agents
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney K, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE et al..  2011.  Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):341-50. Abstract
Antineoplastic Agents, Alkylating
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney K, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE et al..  2011.  Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):341-50. Abstract
McCune JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
Antineoplastic Combined Chemotherapy Protocols
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney K, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE et al..  2011.  Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):341-50. Abstract
Bayes Theorem
McCune JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
Bilirubin
McCune JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
Busulfan
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney K, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE et al..  2011.  Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):341-50. Abstract
Calcineurin
Inamoto Y, Flowers MED, Appelbaum FR, Carpenter PA, Deeg HJ, Furlong T, Kiem H-P, Mielcarek M, Nash RA, Storb R et al..  2011.  A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):1088-92. Abstract
Center-Authored Paper
Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney K, Hilger RA, Scott BL, Kovacsovics TJ, Maziarz RT, Woolfrey AE et al..  2011.  Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):341-50. Abstract